These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Effects of isosorbide-5-mononitrate on exercise-induced hemodynamic changes in angina pectoris. Yokota M; Tsunekawa A; Miyahara T; Kamihara S; Kitamura J; Noda S; Koide M; Tsuzuki M; Sotobata I Am J Cardiol; 1986 Jul; 58(1):53-8. PubMed ID: 3728331 [TBL] [Abstract][Full Text] [Related]
32. Isosorbide-5-mononitrate in the treatment of acute left ventricular failure following acute myocardial infarction. Gammage MD; Murray RG; Littler WA Eur J Clin Pharmacol; 1986; 29(6):639-43. PubMed ID: 3709607 [TBL] [Abstract][Full Text] [Related]
33. Comparative evaluation of a new formulation of isosorbide dinitrate oral spray and sublingual nitroglycerin tablets. Marmor A Am J Cardiol; 1990 Jun; 65(21):43J-45J. PubMed ID: 2112337 [TBL] [Abstract][Full Text] [Related]
34. [Comparative antianginal, hemodynamic and pharmacokinetic effects of isosorbide-2-mononitrate and isosorbide dinitrate in the rat]. Leitold M; Laufen H Arzneimittelforschung; 1983; 33(8):1117-21. PubMed ID: 6685489 [TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of isosorbide-5-mononitrate after oral administration of an extended-release mononitrate formulation versus a standard dinitrate formulation. Kosoglou T; Patrick JE; Cohen A; Radwanski E; Christopher D; Affrime MB Clin Ther; 1995; 17(2):241-51. PubMed ID: 7614524 [TBL] [Abstract][Full Text] [Related]
36. Hemodynamic effects of isosorbide-5-mononitrate in acute and chronic treatment of coronary heart disease. Schuster P; Trieb G; Wiechmann HW Z Kardiol; 1983; 72 Suppl 3():251-4. PubMed ID: 6666229 [TBL] [Abstract][Full Text] [Related]
37. Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients. Döring G J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S74-81. PubMed ID: 1282180 [TBL] [Abstract][Full Text] [Related]
38. Randomized study to evaluate the relation between oral isosorbide dinitrate dosing interval and the development of early tolerance to its effect on left ventricular filling pressure in patients with chronic heart failure. Elkayam U; Roth A; Mehra A; Ostrzega E; Shotan A; Kulick D; Jamison M; Johnston JV; Rahimtoola SH Circulation; 1991 Nov; 84(5):2040-8. PubMed ID: 1934379 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of angiogenesis, tumour growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate. Pipili-Synetos E; Papageorgiou A; Sakkoula E; Sotiropoulou G; Fotsis T; Karakiulakis G; Maragoudakis ME Br J Pharmacol; 1995 Sep; 116(2):1829-34. PubMed ID: 8528567 [TBL] [Abstract][Full Text] [Related]
40. [5-isosorbide mononitrate at rest and on exercise in coronary heart disease: acute and long-term effect]. Jansen W; Osterspey A; Tauchert M; Schmid G; Schell U; Fuchs M; Hombach V; Hilger HH Dtsch Med Wochenschr; 1982 Oct; 107(40):1499-506. PubMed ID: 7117166 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]